Showing results (61-70 of 91) with videos related to

Sort By:
Pageof 10
Annals of the Rheumatic Diseases|December 29, 2010
Tumour necrosis factor alpha-driven IL-32 expression in rheumatoid arthritis synovial tissue amplifies an inflammatory cascadeBas Heinhuis, Marije I Koenders, Piet L van Riel, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 7, 2001
IL-1-independent role of IL-17 in synovial inflammation and joint destruction during collagen-induced arthritisE Lubberts, L A Joosten, B Oppers, et al.
Gene Therapy|January 23, 2002
A tropism-modified adenoviral vector increased the effectiveness of gene therapy for arthritisA C Bakker, F A Van de Loo, L A Joosten, et al.
Annals of the Rheumatic Diseases|May 18, 2010
IL-32gamma and Streptococcus pyogenes cell wall fragments synergise for IL-1-dependent destructive arthritis via upregulation of TLR-2 and NOD2Bas Heinhuis, Marije I Koenders, Fons A van de Loo, et al.
Osteoarthritis and Cartilage|March 10, 2001
Overexpression of active TGF-beta-1 in the murine knee joint: evidence for synovial-layer-dependent chondro-osteophyte formationA C Bakker, F A van de Loo, H M van Beuningen, et al.
Arthritis Research & Therapy|June 18, 2015
Complementary action of granulocyte macrophage colony-stimulating factor and interleukin-17A induces interleukin-23, receptor activator of nuclear factor-κB ligand, and matrix metalloproteinases and drives bone and cartilage pathology in experimental arthritis: rationale for combination therapy in rheumatoid arthritisAnnemarie E M van Nieuwenhuijze, Fons A van de Loo, Birgitte Walgreen, et al.
Arthritis and Rheumatism|April 27, 2011
Tumor necrosis factor-interleukin-17 interplay induces S100A8, interleukin-1β, and matrix metalloproteinases, and drives irreversible cartilage destruction in murine arthritis: rationale for combination treatment during arthritisMarije I Koenders, Renoud J Marijnissen, Isabel Devesa, et al.
Heliyon|December 17, 2024
Association between Clinical Frailty Scale and mortality 24 months after hospitalisation in adult patients with COVID-19Julia Minnema, Melvin Lafeber, Roos S G Sablerolles, et al.
Rheumatology (Oxford, England)|November 16, 2020
Systemic overexpression of interleukin-22 induces the negative immune-regulator SOCS3 and potently reduces experimental arthritis in miceJoyce Aarts, Debbie M Roeleveld, Monique M Helsen, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 6, 2017
Brief Report: Induction of Matrix Metalloproteinase Expression by Synovial Wnt Signaling and Association With Disease Progression in Early Symptomatic OsteoarthritisMartijn H van den Bosch, Arjen B Blom, Fons A van de Loo, et al.
Pageof 10